🔗 Share this article Social Media Content Creators Fueling Unofficial Trade for Unlicensed Slimming Drug An underground market for unlicensed slimming medications is propelled by social media fitness personalities and vendors on communication apps, based on recent findings. Experimental Treatment Acquiring Traction Via Social Media The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to contact these accounts directly for source information, while also obtaining discount codes. Thriving Commerce on Messaging Platforms Separately, a robust market exists on messaging services, where groups with thousands of participants share comparison photos, injection guides and claims of next-day UK delivery. Vendors promote the drug there before redirecting customers to other platforms for purchases. Understanding The Experimental Drug Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic. Healthcare Professionals Voice Concerns However, doctors and chemists have warned that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could result in users administering products of unknown origin. Several experts said the demand for the experimental drug could be linked to the rising price of licensed slimming treatments such as Mounjaro. Regulatory Status and Implementation Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012. Several influencers attempt to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate pharmaceutical, advertising, and customer laws, risking penalties, legal action or prison. Service Reaction and Material Elimination According to the social media company, the service has removed problematic content and banned associated keywords and search suggestions. The company stated it was dedicated to maintaining the service secure and investing in strengthening compliance measures. Digital Marketplace Activities Research also found groups with up to nine thousand participants selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays channels with numerous of users, populated with images of slimming results, glowing reviews and detailed instructions for mixing or administering at home. Within minutes of joining one group, a vendor shared WhatsApp details, where most transactions occur. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage. Product Information and Pricing Inside these communities, posts show dark colored parcels with Royal Mail labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.” Customers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20 milligrams. When questioned how much time a injector should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”. Platform Oversight and Safety Measures A spokesperson for Telegram stated it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”. Healthcare Expert Warnings “Individuals are injecting materials they cannot confirm. Although the research behind retatrutide is sound, these online products may not include what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service. Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With prices rising, patients are turning to social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said. Her team has already encountered patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.” Producer Position A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to potentially significant health risks”.